Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

How important is it to understand the natural history of disease before embarking on drug development ... need can also help direct the development process. Understanding the disease for which ...

Tinlarebant has previously been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug ...

Viva Biotech's approach to drug discovery is grounded in the same core principle: a deep, structural understanding ... reducing downstream development risks and accelerating the overall antibody drug ...

Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative ...

Google I/O 2025 impressively demonstrates that we are in the middle of an AI revolution — and Google wants to be at the ...

“I don’t know which is worse: the process or the policy,” Holtz ... the prohibition on reimportation for all classes of drugs and devices from all Organisation for Economic Co-operation and ...

Around 13 percent of American adults regularly take an antidepressant, according to 2020 data, the most common of which are ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.